The global need for effective medicines is increasing, whilst the biology underlying new drug concepts is becoming increasingly complex. This meeting will outline how our research community is rising to address these challenges by following the early life cycle of new medicine concepts through 3 critical stages: 1) Identifying your target. 2) Drugging your target. 3) Gaining clinical insights. These session themes will run sequentially and blend the most exciting science from early career researchers, commercial organisations and key academic, clinical and industry leaders in the field. In addition, an interactive panel discussion will provide the opportunity to share perspectives on some of the most current and innovative routes though which to translate scientific ideas into impactful therapies. Topics in scope for this scientific program will include:
Target Identification & Validation
Disease-centric biology insights & dealing with increasingly complex target biology
Leveraging emerging platform technologies
Deconvoluting target hit lists
Drugging your target
How new drug formats are changing drug discovery
New concepts in pharmacology – poly-pharmacology, cellular kinetics etc
New models of collaborative drug discovery (panel discussion topic)
Clinical insights
Experimental medicine studies with proprietary and/or essential medicines
Examples of successful clinical translation of new medicine concepts
Bringing patient data insights into the discovery pipeline
Through this joint meeting, being organised by ELRIG and the BPS, we aim to bring together the research community working in the field of new medicine creation with interests in developing their translational research ideas and applying novel technologies and means of collaboration to address critical clinical needs. Join scientists from academia, pharma, biotech and CRO’s either in person or online to hear talks given by speakers at the cutting edge of their field and gain strategic insights into solutions for increasing the success of your therapeutic ideas.
Venue: Web Event Organiser Contact Details: ELRIG UK T: 07484 113971 info@elrig.org
Simon Boulton
Co-founder & VP Science Strategy
Artios Pharma/Senior Group Leader, Francis Crick Institute.